Kathleen Stock, the controversial gender-critical feminist, is at the centre of a heated dispute at Oxford University over her planned appearance to address the Oxford Union on Tuesday evening.

Profound Medical Corp. remains rated Sell due to persistent competitive pressures, missed growth promises, and deteriorating financials. PROF's recent 20% stock spike followed news of a Dallas Medical ...

Profound Medical Corp's TULSA-PRO system has the potential to disrupt the surgical treatment of prostate disease. The company is delivering solid growth in recurring and capital revenues. Despite high ...

The breakfast host interviewed Kathleen Stock after she stepped down from her role as a philosophy lecturer at the University of Sussex. During a heated interview on ITV breakfast show Lorraine, she ...

Profound Medical (NASDAQ:PROF) just reported results for the fourth quarter of 2023. Profound Medical reported earnings per share of -42 cents. This was below the analyst estimate for EPS of -32 cents ...

Profound Medical (NASDAQ:PROF) just reported results for the second quarter of 2024. Profound Medical reported earnings per share of -28 cents. This was above the analyst estimate for EPS of -29 cents ...